Evidence map›Paper›PMID 41104238›Full record

ArticleIranian journal of pharmaceutical research : IJPR

Anti-tumor Effects of

Siyu Yang, Lizhu Zeng, Caiyun Deng, Xianglian Tian, Wenkui Sun, Chengjie Ji, QingLian Zhang

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siyu Yang *School of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Lizhu Zeng *School of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Caiyun DengSchool of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Xianglian TianSchool of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Wenkui SunSchool of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Chengjie JiDepartment of Clinical Laboratory, Jianyang People's Hospital, Jianyang, China.
QingLian ZhangSchool of Laboratory Medicine, Chengdu Medical College, Chengdu, China.ORCID https://orcid.org/0000-0003-1126-9470

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical cancer is among the most prevalent malignancies affecting women globally. This study examines the anti-tumor effects and mechanisms of Methods: The effects of HDW on the proliferation and migration of SiHa and CaSki cells were evaluated through in vitro assays. Additionally, the anti-tumor activity of HDW was assessed in vivo using a xenograft mouse model. To further explore its potential mechanisms, the effects of HDW on apoptosis, the cell cycle, and the IL-17/NF-κB signaling pathway were analyzed. Results: In vitro, HDW dose-dependently reduced the proliferation, colony formation, and migration of SiHa and CaSki cervical cancer cells (P < 0.01). It induced apoptosis by modulating the expression of BCL2, BAX, caspase 3, and cleaved-caspase 3, and caused S-phase cell cycle arrest through suppression of CDK2 and cyclin A (P < 0.05 or P < 0.01). Conclusions: These findings suggest that HDW exerts its anti-tumor effects by inducing apoptosis, causing cell cycle arrest, and inhibiting the IL-17/NF-κB signaling pathway, highlighting its potential as a promising therapeutic candidate for cervical cancer.

Indexed as

Anti-cancer EffectApoptosisCell Cycle ArrestCervical CancerHedyotis diffusa Willd

Identifiers

PMID41104238
PMCPMC12524121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.